Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemoptysis: a 10-year retrospective study

J A Coss-Bu1, R C Sachdeva, J T Bricker

  • 1Section of Critical Care, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030-2399, USA.

Pediatrics
|April 3, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Body composition during growth in children: limitations and perspectives of bioelectrical impedance analysis.

European journal of clinical nutrition·2015
Same author

Modified RIFLE criteria in critically ill children with acute kidney injury.

Kidney international·2007
Same author

Can pediatric residents interpret electrocardiograms?

Pediatric cardiology·2005
Same author

The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.

Oncology reports·2005
Same author

Cardiac, aortic, and pulmonary arteriopathy in HIV-infected children: the Prospective P2C2 HIV Multicenter Study.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2004
Same author

Cost-effectiveness of Project ADAM: a project to prevent sudden cardiac death in high school students.

Pediatric cardiology·2004

Hemoptysis is rare in children. Young adult cystic fibrosis (CF) patients with hemoptysis face higher mortality than those with congenital heart disease (CHD). Blood product transfusion predicts mortality in all patients.

Area of Science:

  • Pediatric Pulmonology
  • Critical Care Medicine
  • Medical Outcomes Research

Background:

  • Hemoptysis (coughing up blood) is infrequent in pediatric care.
  • A 10-year review of hemoptysis cases in a tertiary pediatric hospital was conducted.
  • The study aimed to identify patient characteristics and mortality predictors.

Purpose of the Study:

  • To analyze patient demographics and clinical data for hemoptysis.
  • To determine factors influencing mortality in pediatric hemoptysis cases.
  • To compare outcomes between different primary diagnoses and age groups.

Main Methods:

  • Retrospective review of 228 patients with 246 hemoptysis episodes over 10 years.
  • Patients categorized by age (0-5, 6-10, 11-20, >20 years) and hemoptysis severity.

Related Experiment Videos

  • Primary diagnoses included cystic fibrosis (CF), congenital heart disease (CHD), and other conditions.

    • Main Results:

    • Overall mortality was 13%. Key predictors of mortality included age, hemoptysis amount, blood product transfusion, and fever.
    • Young adult CF patients (>20 years) had higher mortality than young adult CHD patients.
    • Hemoptysis amount predicted mortality solely in CHD patients, while blood product transfusion was a universal mortality predictor.

    Conclusions:

    • Hemoptysis commonly affects young adults with CF and adolescents with CHD.
    • Young adult CF patients with hemoptysis exhibit increased mortality risk compared to young adult CHD patients.
    • Blood product transfusion is a significant predictor of mortality across all studied patient groups.